Prostate carcinoma cells have a preference to form bone metastasis driven by the androgen receptor, which induces the expression of CaMKK2 as its key downstream signaling protein playing a fundamental role in tumor cell migration and invasiveness via the CaMKK2/AMPK pathway [221]. Here, CAMKK2 is linked to neoplasm.